<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4891">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03043261</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00078272</org_study_id>
    <nct_id>NCT03043261</nct_id>
  </id_info>
  <brief_title>Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation</brief_title>
  <acronym>EMERGE</acronym>
  <official_title>Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility,
      usability, effectiveness and relevance of an integrated psycho-behavioral intervention on
      heart failure patients in order to increase support, outreach and general well-being of
      these patients following hospitalization due to heart failure exacerbation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subject retention</measure>
    <time_frame>6 month</time_frame>
    <description>Percentage of subjects who complete the intervention</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>Psycho-Behavioral Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Williams LifeSkills modules which cover 10 core skills designed to improve coping skills, stress management and interpersonal relationships: 1) being aware of negative thoughts and feelings, 2) making a decision, 3) deflection skills, 4) problem solving or action skills, 5) assertion, 6) saying &quot;no&quot;, in addition to the following preventive skills: 7) speaking up, 8) listening, 9) empathy and 10) increasing positives</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Williams LifeSkills</intervention_name>
    <description>Online multi-media interactive training modules which address 10 core skills to improve coping, stress management and interpersonal relationships.</description>
    <arm_group_label>Psycho-Behavioral Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SSRI</intervention_name>
    <description>Eligible participants who score 9 or higher on the PHQ-9 and who opt in will be given a prescription from the study PI for one of four SSRI medications (sertraline, citalopram, paroxetine or escitalopram).</description>
    <arm_group_label>Psycho-Behavioral Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male and female patients, age ≥ 18 hospitalized at Duke inpatient service
             because of heart failure

          -  NYHA Class ≥ II

        Exclusion Criteria:

          -  Significant cognitive impairment, indicated as a mini-mental state exam (MMSE) total
             score of 23 or lower

          -  Lack of convenient internet access outside of hospital

          -  Alcohol or other drug dependence/abuse within past 90 days as evaluated by review of
             medical record and patient interview (SCID)

          -  Severe physical disability (visual, sensory or motor) that may interfere with study
             participation (assessment, online interactive learning)

          -  History or presence of psychoses, bipolar disorder, and/or severe personality
             disorders as evaluated by review of medical record and patient interview (SCID)

          -  Life-threatening co-morbidity with the likelihood of 50% mortality in one year

          -  Active suicidal ideations

          -  Female patients of childbearing potential

          -  Treatment with electroconvulsive therapy or transcranial magnetic stimulation within
             past 90 days

          -  Uncorrected hypothyroidism or hyperthyroidism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Jiang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Wilson, B.A.</last_name>
    <phone>919-681-4367</phone>
    <email>j.wilson@duke.edu</email>
  </overall_contact>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>February 2, 2017</lastchanged_date>
  <firstreceived_date>February 2, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CHF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
